e-med
[Top] [All Lists]

[e-med] USA-Marketing pharmaceutique sur les bancs de la fac

USA-Marketing pharmaceutique sur les bancs de la fac

- 07/09/2005 -  L'industrie pharmaceutique consacre une somme importante de
son budget à sa communication auprès des professionnels de santé. Ces
contacts avec la profession médicale peuvent débuter très tôt, dès les
premières années d'étude, comme le montre une enquête américaine.

Cette étude publiée dans la dernière livraison du JAMA indique qu'en moyenne
un étudiant américain de troisième année de médecine reçoit chaque semaine
de l'industrie pharmaceutique un cadeau ou est invité à une activité
sponsorisée par un laboratoire. Plus de 90% des étudiants interrogés ont
déclaré avoir été invités par un médecin à un repas financé par un
laboratoire pharmaceutique mais 68,8% estiment que les cadeaux reçus ne
modifieront pas leur pratique ou leurs choix de prescription.

"Notre étude s'ajoute à de précédentes études en mettant en évidence les
expériences et les attitudes d'un large nombre d'étudiants dans diverses
écoles de médecine et elle témoigne de l'acceptation de la valeur des
cadeaux ou activités sponsorisés par l'industrie pharmaceutique", écrivent
les auteurs. Ces derniers ajoutent qu'il faudra désormais s'attacher à
étudier les moyens susceptibles de limiter ces attitudes dans le but
d'assurer la plus grande indépendance des médecins dès leur formation.

Source : JAMA. 2005; 294:1034 - 1042.
Article entier : http://jama.ama-assn.org/cgi/content/full/294/9/1034
***********************
Medical Students' Exposure to and Attitudes About Drug Company Interactions
A National Survey
Frederick S. Sierles, MD; Amy C. Brodkey, MD; Lynn M. Cleary, MD; Frederick
A. McCurdy, MD, PhD, MBA; Matthew Mintz, MD; Julia Frank, MD; D. Joanne
Lynn, MD; Jason Chao, MD; Bruce Z. Morgenstern, MD; William Shore, MD; John
L. Woodard, PhD

JAMA. 2005;294:1034-1042.

ABSTRACT

Context  While exposure to and attitudes about drug company interactions
among residents have been studied extensively, relatively little is known
about relationships between drug companies and medical students.
Objective  To measure third-year medical students' exposure to and attitudes
about drug company interactions.
Design, Setting, and Participants  In 2003, we distributed a 64-item
anonymous survey to 1143 third-year students at 8 US medical schools,
exploring their exposure and response to drug company interactions. The
schools' characteristics included a wide spectrum of ownership types,
National Institutes of Health funding, and geographic locations. In 2005, we
conducted a national survey of student affairs deans to measure the
prevalence of school-wide policies on drug company-medical student
interactions.
Main Outcome Measures  Monthly frequency of students' exposure to various
activities and gifts during clerkships, and attitudes about receiving gifts.
Results  Overall response rate was 826/1143 (72.3%), with range among
schools of 30.9%-90.7%. Mean exposure for each student was 1 gift or
sponsored activity per week. Of respondents, 762/818 (93.2%) were asked or
required by a physician to attend at least 1 sponsored lunch. Regarding
attitudes, 556/808 (68.8%) believed gifts would not influence their
practices and 464/804 (57.7%) believed gifts would not affect colleagues'
practices. Of the students, 553/604 (80.3%) believed that they were entitled
to gifts. Of 183 students who thought a gift valued at less than $50 was
inappropriate, 158 (86.3%) had accepted one. The number of students who
simultaneously believed that sponsored grand rounds are educationally
helpful and are likely to be biased was 452/758 (59.6%). Students at 1
school who had attended a seminar about drug company-physician relationships
were no more likely than the nonattending classmates to show skepticism. Of
the respondents, 704/822 (85.6%) did not know if their school had a policy
on these relationships. In a national survey of student affairs deans, among
the 99 who knew their policy status, only 10 (10.1%) reported having
school-wide policies about these interactions.
Conclusions  Student experiences and attitudes suggest that as a group they
are at risk for unrecognized influence by marketing efforts. Research should
focus on evaluating methods to limit these experiences and affect the
development of students' attitudes to ensure that physicians' decisions are
based solely on helping each patient achieve the greatest possible benefit.

<Prev in Thread] Current Thread [Next in Thread>